Morgan Stanley vs Rocket Lab USA Inc — how do they compare? Morgan Stanley trades at $189.1 (market cap $294.39B), while Rocket Lab USA Inc trades at $69.55 (market cap $43.74B). The key difference: Morgan Stanley is far larger — about 6.7× Rocket Lab USA Inc's market cap, and Morgan Stanley pays a 2.45% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Morgan Stanley for 93 Days and Rocket Lab USA Inc for 29 Days on average.
| MS | RKLB | |
|---|---|---|
Market Cap | $294.39B | $43.74B |
Volume | 5,836,423 | 22,892,581 |
Sector | Financials | Industrials |
52-Week High | $228.42 | $150.23 |
52-Week Low | $151.86 | $39.48 |
Typical Hold Time | 93 Days | 29 Days |
Enterprise Value | $660.04B | $41.57B |
Dividend Yield | 2.45% | — |
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $189.71, down 0.66% with bearish technical signals despite strong fundamentals. The company has delivered three consecutive earnings beats with Q2 2026 EPS of $3.46 beating expectations by $0.57. Revenue growth accelerated to $66.0 billion in 2025 with net income margin expanding to 27.59%. Analyst consensus remains bullish with 55.77% buy ratings and a $229.25 price target representing 21% upside potential.
The investment case balances strong profitability and growth opportunities in wealth management and AI financing against concerning cash flow trends and technical weakness. While valuation appears reasonable at 15.14 P/E, investors face risks from volatile operating cash flows and rising debt levels. The stock offers attractive upside to analyst targets but requires monitoring of capital markets recovery timing.
Rocket Lab (RKLB) trades at $71.92, down 4.18% today, with neutral technical signals and strong analyst support. The company recently secured its largest commercial Electron deal - 20 launches with Synspective - boosting its backlog past 100 missions. Despite negative profitability metrics, revenue growth continues with 2026 projections showing improvement from 2025's $602 million. The stock trades at elevated valuation multiples with P/S of 51.96 and P/B of 12.52.
RKLB presents a growth story with significant contract wins and expanding launch capacity, though profitability remains elusive. The 76% analyst buy rating and $107 consensus target suggest substantial upside potential. Key risks include intense SpaceX competition, high cash burn, and valuation concerns. Investors must weigh growth trajectory against persistent losses and competitive pressures in the evolving space industry.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →